Purpose of this Study
Participants will monitor their blood pressure at home and share the results with the study team. The study includes one baseline visit, three follow up phone visits, health surveys, and review of medical records. Participation lasts about 3 months.
Who Can Participate?
Eligibility
Participants may be able to join if they are adults with resistant high blood pressure that has not responded well to standard blood pressure medicines or who cannot tolerate those medicines. Researchers will study how different treatment options work in these patients.
Age Range
18-110
Sex/Genders
Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
No
What is Involved?
Description
This study is evaluating how well different treatments work for people with resistant high blood pressure. Researchers want to learn which treatments are safest and most effective in real world patients, including newer medicines and procedures, and identify which patients benefit most from each option.
Locations
Duke University Hospital
Visit Timing
Weekdays
Compensation
Yes
Spanish Materials Available
No
Study Details
Full Title
Early Patient Experience Initiative (IMPACT-HTN)
Principal Investigator
Sreekanth
Vemulapalli
Protocol Number
PRO00120580
NCT ID
NA
Phase
N/A
Enrollment Status
Pending Open to Enrollment